Author: Jonathan Lustri As a Life Sciences consultant, I get involved in many different aspects of MES [manufacturing execution system] projects. In a recent project, I helped define the project execution plan. I knew Emerson’s biotech customer was highly concerned about the overall usability of the solution design as well as the acceptance of the […]
In an earlier post, Five Strategies for Mitigating Automation Project Risk, we highlighted the importance of prototyping: Risks in budget, schedule, changes, and project execution can be reduced with a prototyping strategy. Prototyping helps incorporate operational philosophies into the upfront engineering, helps ensure consistent look and feel, and provides a visual medium to communicate designs […]
At the recent conference for pharmaceutical and biotech manufacturers, Interphex 2012, Pharmaceutical Manufacturing magazine Editor in Chief Agnes Shanley discussed trends in the industry’s use of process analytical technology (PAT) and quality by design (QbD) with Emerson’s Director of Life Sciences Industry Consulting, Chris Amstutz. Their discussion was captured in this 4:48 YouTube video, Emerson […]
As a follow up to the post, Using Operational Excellence Techniques to Understand and Solve Business Problems, Emerson’s Michalle Adkins shared a great story of one pharmaceutical manufacturer’s path to justify technology to help their business objective to reduce deviations, eliminate redundant work, and improve production efficiency, including the product release process. The current method […]
In an earlier post I mentioned how Emerson’s Shenling Yang had taken an assignment in Shanghai, China. She’s bringing her expertise in operations management and the Syncade software gained while executing projects as a member of the Life Sciences industry team. Shenling had some thoughts on the FDA Globalization Act of 2009 and its impact […]
Powered by WordPress